藥物成份
共有 21387 個藥物成份
(1) OC-LIGHT: 1.PVA binding glass fiber, blue latex, bovine serum albumin, Tris (hydroxymethyl) aminomethane, sucrose, mouse anti-human IgG, rabbit anti-human IgG. 2.Nitrocellulose, mouse anti-human IgG, anti-mouse IgG rabbit IgG, sodium monophosphate, sodium diphosphate, sodium chloride.\n(2) Sampling bottle: HEPES, sodium hydroxide, sodium chloride, sodium azide, bovine serum albumin.\n
(1)Solid Phase 20.0 ml containing Streptavidin-coated paramagnetic microparticles preformed with biotinylated HIV antigens (~1.0μg/mL) in buffer with bovine serum albumin, goat serum, surfactant, and preservatives.\n(2)Lite Reagent 10.0 ml containing recombinant HIV antigens, labeled with acridinium ester in buffer with bovine serum albumin, mouse lgG, goat serum, surfactant, and preservatives.\n(3)Ancillary Lite Reagent 10.0 ml containing recombinant HIV antigens labeled with acridinium ester in buffer with bovine serum albumin, mouse lgG, goat serum, surfactant, and preservatives.\n(4)EHIV calibrator vials: 2.0 ml/vial processed human plasma negative for antibodies toHIV spiked with antibodies to HIV-1, sodium azide (<0.1%) and preservatives.\n\nEHIV quality control material containing 7.0 ml/vial processed human plasma nonreactive for HIV, reactive for HIV-1, and reactive for HIV-2 with preservatives.
(Chloral Hydrate), (Ethylene Glycol, acetic acid 99-100%), (Purified water, Sodium iodide, Aluminium Sulfate, Propyleneglycol), (Ethanol, methanol), (wasser), (Ethylene Glycol, acetic acid 99-100%), (Ethanol, methanol), (Ethanol, methanol), (Ethanol, methanol, acetic acid, 99-100%)
(Reagent)M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 mL: Streptavidin-coated microparticles, 0.72 mg/mL; binding capacity: 470 ng biotin/mg microparticles; preservative.R1 Anti-digoxin-Ab~Ru(bpy)32+ (gray cap), 1 bottle, 10ml: Monoclonal anti-digoxin antibody (mouse) labeled with ruthenium complex 15 μg/L; monoclonal anti-digoxin antibody (mouse) 5mg/L, phosphate buffer 100 mmol/L, pH 7.0; preservative.R2 Digoxin-dervative~biotin (black cap), 1 bottle, 10ml: Biotinylated digoxigenin 1.06 ng/ml; biotin 15μg/L; phosphate buffer 100 mmol/L, pH 7.0 ; preservative.(CalSet)DIGO Cal1: 2 bottles, each for 1.5mL of calibrator 1DIGO Cal2: 2 bottles, each for 1.5mL of calibrator 2Digoxin in two concentration ranges (approx. 0.61 ng/mL or 0.78 nmol/L and approx. 3.61 ng/mL or 4.62 nmol/L) in a buffer/protein (bovine serum) matrix.
(Reagent)M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 ml:Streptavidin-coated microparticles, 0.72 mg/mL, binding capacity: 470 ng biotin/mg microparticles; preservative.R1 Anti-CK-MB-Ab~biotin(gray cap), 1 bottle, 10 ml: Biotinylated monoclonal anti-CK-MB antibody(mouse)1.2mg/L; phosphate buffer 100 mmol/L, pH 7.0; preservative.R2 Anti-CK-MB~Ab~Ru(bpy)32+(black cap),1 bottle, 10mL:Monoclonal anti-CK-MB antibody (mouse) labeled with ruthenium complex 1.2 mg/L; phosphate buffer 100 mmol/L, pH 7.0; preservative.(CalSet)CK-MB STAT Cal1:2 bottles, each for 1.0mL of calibrator 1CK-MB STAT Cal2:2 bottles, each for 1.0mL of calibrator 2CK-MB (human) in two concentration ranges (approx. 1.5ng/mL and approx.25ng/mL) in a human serum matrix.
(Reagent)M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5mL：Streptavidin-coated microparticles, 0.72mg/mL； binding capacity：470 ng biotin/mg microparticles； preservative.R1 Anti-CK-MB-Ab~biotin (gray cap), 1 bottle, 10ml： Biotinylated monoclonal anti-CK-MB antibody (mouse) 1.2mg/L； Phosphate buffer 100 mmol/L, pH 7.0； preservative.R2 Anti-CK-MB~Ab~Ru(bpy)32+ (black cap), 1 bottle, 10ml： Monoclonal anti-CK-MB-antibody (mouse) labeled with ruthenium complex 1.2mg/L; phosphate buffer 100 mmol/L, pH 7.0； preservative.(CalSet)CK-MB Cal1：2 bottles, each for 1.0mL of calibrator 1CK-MB Cal2：2 bottles, each for 1.0mL of calibrator 2CK-MB (human) in two concentration ranges (approx. 1.5 ng/mL and 25 ng/mL) in a human serum matrix.
(ug/mL) Amikacin (8-32), Amoxicillin/Clavulanate(4/2-16/8), Ampicillin(4-16), Aztreonam(2-16), Cefazolin(4-16), Cefotaxime(4-32), Cefoxitin(4-16), Ceftazidime(1-16), Cefuroxime(4-16), Cephalothin(4-16), Ciprofloxacin(0.5-2), Gentamicin(2-8), Imipenem(1-8), Levofloxacin(1-4), Meropenem(1-8), Moxifloxacin(1-4), Nitrofurantoin(16-64), Piperacillin(4-64), Piperacillin/Tazobactam(4/4-64/4), Ticarcillin/Clavulanic Acid(8/2-64/2), Tobramycin(2-8), Trimethoprim/Sulfamethoxazole(0.5/9.5-2/38), ESBL Cefotaxime/Clavulanate(<9), Ceftazidime/Clavulanate(ESBL)(<9), Cefpodoxime-proxetil (ESBL)(<9), Ceftazidime(ESBL)(<9), Ceftriaxone/Clavulanate(ESBL)(<9)
*30 CK-MB Strips：\nSerum diluent：Tris-NaCl (0.05 mol/l, pH 7.4), protein and chemical stabilizers, 0.9 g/l sodium azide (300 μl).\nWash buffer：Tris-NaCl (0.05 mol/l, pH 7.4), protein stabilizers, 0.9 g/l sodium azide (600 μl).\nWash buffer：Tris-NaCl (0.05 mol/l, pH 7.4), surfactant, 0.9 g/l sodium azide (600 μl).\nConjugate：alkaline phosphatase labeled anti-CK-MM polyclonal antibody Fab’fragment (goat), Tris-NaCl (0.05 mol/l, pH 6), protein stabilizers, 0.9 g/l sodium azide (400 μl).\nCuvette with substrate：4-Methyl-umbelliferyl phosphate (0.6 mmol/l) + diethanolamine(DEA*) (0.62 mol/l or 6.6%, pH 9.2) + 1 g/l sodium azdie (300 μl).\n*30 CK-MB SPRs：\nInterior of SPRs coated with monoclonal anti-CK-MB immunoglobulins (mouse).\n*CK-MB Control：1 × 3 mL\nProtein base (BSA) + chemical stabilizers + human CK-MB.\n*CK-MB Calibrator：1 × 3 mL\nProtein base (BSA) + chemical stabilizers + human CK-MB.\nReconstitution solvent：1 × 20 mL\nDemineralized water + 0.9 g/l sodium azide.\n*MLE card